Evidence map›Paper›PMID 32762277›Full record

ArticleMolecular pain

Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats.

Andrea M Stevens, Muzamil Saleem, Brooke Deal, Jelena Janjic, John A Pollock

Open access · goldAbstract read
In one paragraph

Article in Molecular pain. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Andrea M StevensBayer School of Natural and Environmental Sciences, Duquesne University, Pittsburgh, PA, USA.
Muzamil SaleemBayer School of Natural and Environmental Sciences, Duquesne University, Pittsburgh, PA, USA.ORCID 0000-0001-9910-136X
Brooke DealBayer School of Natural and Environmental Sciences, Duquesne University, Pittsburgh, PA, USA.
Jelena JanjicChronic Pain Research Consortium, Duquesne University, Pittsburgh, PA, USA.
John A PollockBayer School of Natural and Environmental Sciences, Duquesne University, Pittsburgh, PA, USA.ORCID 0000-0001-6602-3676
Bayer (United States) · USDuquesne University · US

Funding

Theranostic Pain Nanomedicines: imaging inflammation, reducing pain and need for opioidsR21DA039621 · NIDA · DUQUESNE UNIVERSITY · PI JANJIC, JELENA M · 2015 to 2016
$328k
NIDA NIH HHS R21 DA039621
6 · The paper itself

Abstract

Chronic constriction injury of the sciatic nerve in rats causes peripheral neuropathy leading to pain-like behaviors commonly seen in humans. Neuropathy is a leading cause of neuropathic pain, which involves a complex cellular and molecular response in the peripheral nervous system with interactions between neurons, glia, and infiltrating immune cells. In this study, we utilize a nonsteroidal anti-inflammatory drug -loaded nanoemulsion to deliver the cyclooxygenase-2 inhibitor, Celecoxib, directly to circulating monocytes following nerve injury, which provides long-lasting pain relief. However, it is not fully understood how cyclooxygenase-2 inhibition in a macrophage traveling to the site of injury impacts gene expression in the dorsal root ganglia. To elucidate aspects of the molecular mechanisms underlying pain-like behavior in chronic constriction injury, as well as subsequent pain relief with treatment, we employ RNAseq transcriptome profiling of the dorsal root ganglia associated with the injured sciatic nerve in rats. Using high throughput RNA sequencing in this way provides insight into the molecular mechanisms involved in this neuroinflammatory response. We compare the transcriptome from the dorsal root ganglias of the following study groups: chronic constriction injury animals administered with cyclooxygenase-2 inhibiting celecoxib-loaded nanoemulsion, chronic constriction injury animals administered with vehicle treatment, a drug-free nanoemulsion, and a group of naïve, unoperated and untreated rats. The results show an extensive differential expression of 115 genes. Using the protein annotation through evolutionary relationship classification system, we have revealed pain-related signaling pathways and underlying biological mechanisms involved in the neuroinflammatory response. Quantitative polymerase chain reaction validation confirms expression changes for several genes. This study shows that by directly inhibiting cyclooxygenase-2 activity in infiltrating macrophages at the injured sciatic nerve, there is an associated change in the transcriptome in the cell bodies of the dorsal root ganglia.

Indexed as

AnimalsCelecoxibCyclooxygenase 2Cyclooxygenase 2 InhibitorsGanglia, SpinalGene Expression RegulationGene OntologyInflammationMacrophagesMaleMonocytesNanomedicineNeuralgiaPain ManagementRatsRats, Sprague-DawleyCelecoxibCyclooxygenase 2Cyclooxygenase 2 Inhibitorscelecoxibchronic constriction injurynanoemulsionneuroinflammationNeuropathic painRNA sequencing

Identifiers

PMID32762277
PMCPMC7543154
OpenAlexW3047745673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.